Tsuyoshi Suda

Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: In reference to hepatitis viral infection

Shigeru Matsui, Takafumi Ichida, Masashi Watanabe et al. · Journal of Gastroenterology and Hepatology · 2000 · 40 citations · Full text

Medicine, Oncology, Pathology +17

BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma

Han Chen, Kouki Nio, Taro Yamashita et al. · Molecular Oncology · 2021 · 29 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma

Tsuyoshi Suda, Taro Yamashita, Taro Yamashita et al. · International Journal of Molecular Sciences · 2022 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +17

Simultaneous occurrence of autoimmune pancreatitis and sclerosing cholangitis as immune-related adverse events of pembrolizumab

Tsuyoshi Suda, Koji Kurokawa, Eiki Matsushita · BMJ Case Reports · 2021 · 17 citations · Full text

Medicine, Immunology, Pathology +17

A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma

Tomoyuki Hayashi, Taro Yamashita, Hikari Okada et al. · Anticancer Research · 2017 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17